Companies › LTRN

Lantern Pharma Inc (LTRN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001763950 · EDGAR filings · Updated 2026-07-23

Lantern Pharma Inc (LTRN) has reported institutional ownership of 18.4%, with 32 institutional managers holding positions valued at $2.83M per the latest 13F reporting period. SEC filings include an active substantial-doubt (going concern) disclosure per the filings.

Filings this week (1)

• 2026-07-23 — SCHEDULE 13G/A filed

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

• 2026-06-18 — EFFECT filed
• 2026-06-12 — Registration statement (S-1) filed
• 2026-06-02 — Current report (8-K) filed
• 2026-05-21 — D filed
• 2026-05-15 — SCHEDULE 13D/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, Lantern Pharma Inc has 32 institutional holders and institutional ownership of 18.4%.

Insider activity

Insiders reported 70 transactions (0 buys, 70 sells) across 5 reporting insiders, with a net reported value of −$1.00M.

Data flags from SEC filings

Related companies

IRIDEX CORP (IRIX) · Telomir Pharmaceuticals Inc (TELO) · Celularity Inc (CELU) · SERINA THERAPEUTICS INC (SER) · ONCOLYTICS BIOTECH INC COM NEW (ONCY) · Bolt Biotherapeutics Inc (BOLT)